Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Costello Syndrome | 8 | 2022 | 17 | 2.260 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2019 | 44 | 1.540 |
Why?
|
| Behavior Therapy | 4 | 2022 | 256 | 1.390 |
Why?
|
| Child Behavior Disorders | 3 | 2016 | 68 | 1.240 |
Why?
|
| Disorders of Sex Development | 6 | 2019 | 80 | 1.160 |
Why?
|
| Gender Identity | 4 | 2023 | 68 | 1.070 |
Why?
|
| Psychotherapy, Brief | 2 | 2019 | 48 | 0.980 |
Why?
|
| Transgender Persons | 2 | 2023 | 57 | 0.960 |
Why?
|
| Child Behavior | 2 | 2019 | 230 | 0.860 |
Why?
|
| Problem Behavior | 1 | 2022 | 36 | 0.790 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 213 | 0.680 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 156 | 0.660 |
Why?
|
| Hypothalamic Diseases | 1 | 2019 | 37 | 0.660 |
Why?
|
| Hamartoma | 1 | 2019 | 56 | 0.650 |
Why?
|
| Parenting | 2 | 2013 | 324 | 0.580 |
Why?
|
| Adaptation, Psychological | 4 | 2013 | 459 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2014 | 783 | 0.560 |
Why?
|
| Models, Statistical | 1 | 2017 | 447 | 0.470 |
Why?
|
| Abnormalities, Multiple | 5 | 2019 | 962 | 0.440 |
Why?
|
| Mothers | 1 | 2016 | 346 | 0.440 |
Why?
|
| Verbal Learning | 1 | 2013 | 66 | 0.430 |
Why?
|
| Depressive Disorder | 1 | 2016 | 450 | 0.420 |
Why?
|
| Child | 24 | 2022 | 24058 | 0.420 |
Why?
|
| Cognition | 3 | 2009 | 732 | 0.420 |
Why?
|
| Stress, Psychological | 2 | 2014 | 555 | 0.410 |
Why?
|
| Child Development | 1 | 2014 | 249 | 0.400 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 369 | 0.390 |
Why?
|
| Neuroimaging | 1 | 2014 | 324 | 0.390 |
Why?
|
| Parent-Child Relations | 1 | 2013 | 246 | 0.380 |
Why?
|
| Behavioral Symptoms | 1 | 2011 | 26 | 0.370 |
Why?
|
| Cognition Disorders | 2 | 2014 | 551 | 0.360 |
Why?
|
| Child, Preschool | 16 | 2020 | 13775 | 0.360 |
Why?
|
| Memory | 1 | 2013 | 357 | 0.340 |
Why?
|
| Behavior | 1 | 2009 | 75 | 0.340 |
Why?
|
| Parents | 4 | 2022 | 1016 | 0.330 |
Why?
|
| Adolescent | 19 | 2023 | 18934 | 0.330 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2013 | 70 | 0.330 |
Why?
|
| Syndrome | 4 | 2008 | 1109 | 0.320 |
Why?
|
| Consensus | 1 | 2012 | 606 | 0.320 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 264 | 0.300 |
Why?
|
| Depression | 1 | 2016 | 1214 | 0.300 |
Why?
|
| Humans | 39 | 2023 | 122287 | 0.300 |
Why?
|
| Polyhydramnios | 1 | 2007 | 51 | 0.300 |
Why?
|
| Neurocognitive Disorders | 2 | 2020 | 67 | 0.290 |
Why?
|
| Failure to Thrive | 1 | 2007 | 89 | 0.290 |
Why?
|
| Child Health Services | 1 | 2008 | 86 | 0.290 |
Why?
|
| Female | 25 | 2019 | 64880 | 0.270 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2018 | 34 | 0.270 |
Why?
|
| Patient Care Team | 2 | 2016 | 539 | 0.260 |
Why?
|
| Male | 24 | 2020 | 59515 | 0.260 |
Why?
|
| Urogenital Abnormalities | 2 | 2020 | 163 | 0.260 |
Why?
|
| Developmental Disabilities | 4 | 2020 | 682 | 0.250 |
Why?
|
| Patient Compliance | 4 | 2013 | 464 | 0.250 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 676 | 0.250 |
Why?
|
| Dwarfism | 2 | 2020 | 98 | 0.220 |
Why?
|
| Decision Making | 1 | 2009 | 650 | 0.220 |
Why?
|
| Intellectual Disability | 2 | 2007 | 1011 | 0.210 |
Why?
|
| Social Stigma | 1 | 2023 | 71 | 0.200 |
Why?
|
| Sex Reassignment Procedures | 3 | 2017 | 18 | 0.200 |
Why?
|
| Terminology as Topic | 2 | 2017 | 226 | 0.200 |
Why?
|
| Hyperglycemia | 2 | 2014 | 221 | 0.200 |
Why?
|
| Noonan Syndrome | 1 | 2022 | 29 | 0.200 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 22 | 0.180 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 43 | 0.180 |
Why?
|
| Phenotype | 6 | 2020 | 4150 | 0.180 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 240 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 105 | 0.170 |
Why?
|
| Mental Health | 1 | 2023 | 342 | 0.170 |
Why?
|
| Heart Defects, Congenital | 4 | 2019 | 1799 | 0.170 |
Why?
|
| Adult | 11 | 2020 | 28728 | 0.160 |
Why?
|
| Puberty | 2 | 2016 | 94 | 0.160 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 134 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 408 | 0.160 |
Why?
|
| Young Adult | 6 | 2020 | 8759 | 0.150 |
Why?
|
| Medicaid | 1 | 2021 | 239 | 0.150 |
Why?
|
| Sex Determination Processes | 1 | 2017 | 12 | 0.150 |
Why?
|
| Genes, ras | 2 | 2008 | 96 | 0.150 |
Why?
|
| Sex Counseling | 1 | 2017 | 7 | 0.140 |
Why?
|
| Mythology | 1 | 2017 | 9 | 0.140 |
Why?
|
| Comorbidity | 1 | 2022 | 1490 | 0.140 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 1283 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2018 | 274 | 0.140 |
Why?
|
| Intelligence Tests | 2 | 2007 | 57 | 0.130 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 17 | 0.130 |
Why?
|
| Mutation | 4 | 2011 | 5734 | 0.130 |
Why?
|
| Anxiety | 1 | 2023 | 950 | 0.130 |
Why?
|
| Turner Syndrome | 1 | 2016 | 46 | 0.130 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 76 | 0.130 |
Why?
|
| Cohort Studies | 4 | 2013 | 4642 | 0.130 |
Why?
|
| Social Behavior | 1 | 2017 | 206 | 0.130 |
Why?
|
| Ectromelia | 1 | 2015 | 5 | 0.130 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2015 | 28 | 0.130 |
Why?
|
| Sexual Development | 2 | 2019 | 23 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 107 | 0.120 |
Why?
|
| Encephalocele | 1 | 2015 | 51 | 0.120 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 312 | 0.120 |
Why?
|
| Infant | 6 | 2017 | 12301 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 1244 | 0.120 |
Why?
|
| Heart | 1 | 2019 | 723 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 263 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 921 | 0.110 |
Why?
|
| Language Tests | 1 | 2013 | 24 | 0.110 |
Why?
|
| Family | 1 | 2016 | 565 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 93 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 230 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 191 | 0.110 |
Why?
|
| Age of Onset | 1 | 2014 | 576 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2013 | 139 | 0.100 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 3 | 0.100 |
Why?
|
| Endocrinology | 1 | 2014 | 139 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2014 | 321 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2017 | 8096 | 0.100 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2013 | 153 | 0.100 |
Why?
|
| Brain | 3 | 2019 | 2937 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2013 | 445 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2777 | 0.090 |
Why?
|
| United States | 4 | 2021 | 10487 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2009 | 10 | 0.080 |
Why?
|
| Risk Factors | 5 | 2015 | 9901 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3626 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2009 | 123 | 0.080 |
Why?
|
| Facial Asymmetry | 1 | 2008 | 18 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2009 | 308 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1238 | 0.070 |
Why?
|
| Texas | 2 | 2013 | 3528 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 5013 | 0.070 |
Why?
|
| Pregnancy | 4 | 2018 | 7092 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 412 | 0.070 |
Why?
|
| Motor Activity | 1 | 2009 | 507 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 320 | 0.060 |
Why?
|
| Heterozygote | 1 | 2007 | 675 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2008 | 245 | 0.060 |
Why?
|
| Pediatrics | 1 | 2014 | 1139 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2013 | 12041 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1191 | 0.060 |
Why?
|
| Mass Screening | 1 | 2011 | 778 | 0.060 |
Why?
|
| Vocabulary | 1 | 2004 | 23 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 473 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2008 | 525 | 0.060 |
Why?
|
| Face | 2 | 2019 | 178 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 188 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 581 | 0.050 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 580 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1165 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 15849 | 0.050 |
Why?
|
| ras Proteins | 1 | 2022 | 135 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 207 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2021 | 61 | 0.050 |
Why?
|
| Quality of Life | 1 | 2010 | 1913 | 0.040 |
Why?
|
| Virilism | 1 | 2018 | 14 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 2525 | 0.040 |
Why?
|
| Hormones | 1 | 2019 | 189 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 194 | 0.040 |
Why?
|
| Sex Preselection | 1 | 2017 | 7 | 0.040 |
Why?
|
| Gender Dysphoria | 1 | 2017 | 6 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2017 | 14 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 21 | 0.040 |
Why?
|
| Greece, Ancient | 1 | 2017 | 10 | 0.040 |
Why?
|
| Sex Reassignment Surgery | 1 | 2017 | 10 | 0.040 |
Why?
|
| History, Ancient | 1 | 2017 | 54 | 0.040 |
Why?
|
| Ovulation Induction | 1 | 2016 | 60 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 270 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1579 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Genitalia | 1 | 2015 | 35 | 0.030 |
Why?
|
| Gonads | 1 | 2015 | 37 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 511 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 125 | 0.030 |
Why?
|
| Disclosure | 1 | 2015 | 153 | 0.030 |
Why?
|
| Androgens | 1 | 2015 | 257 | 0.030 |
Why?
|
| Neoplasms | 3 | 2015 | 2753 | 0.030 |
Why?
|
| Estrogens | 1 | 2015 | 506 | 0.030 |
Why?
|
| Informed Consent | 1 | 2015 | 339 | 0.030 |
Why?
|
| Southwestern United States | 1 | 2011 | 45 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3447 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 552 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 710 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 605 | 0.020 |
Why?
|
| Psychology | 1 | 2011 | 57 | 0.020 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2011 | 72 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2534 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3050 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 1103 | 0.020 |
Why?
|
| Family Relations | 1 | 2010 | 69 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 111 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 4510 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 776 | 0.020 |
Why?
|
| Farnesyltranstransferase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2008 | 14 | 0.020 |
Why?
|
| Pyloric Stenosis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 749 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 74 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 90 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 1362 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2030 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 857 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1060 | 0.020 |
Why?
|
| Hospitalization | 1 | 2014 | 1727 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 792 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2010 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2080 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 582 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 2933 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 2371 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6181 | 0.020 |
Why?
|
| Caregivers | 1 | 2010 | 561 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3307 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2797 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 3109 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 25636 | 0.010 |
Why?
|